Is AM Diagnostics listed on the ASX?

The supplier of Australia's only approved at-home COVID-19 tests is the talk of the ASX today.

| More on:
Woman prepares to insert a swab in her nose to test for COVID-19 at home.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

AM Diagnostics has been on the radar of many ASX-watchers recently.

Particularly, after at-home COVID-19 antigen rapid tests, supplied by the Perth-based Australian company, received approval from the Therapeutic Goods Association (TGA) this week.  

Australians might be able to choose between one of three at-home COVID-19 rapid antigen tests from 1 November. All three are supplied by AM Diagnostics and provide results within 15 minutes.

AM Diagnostics leads Australian at-home testing

According to reporting by The Australian, the TGA's thumbs-up means Australians might soon be able to buy rapid COVID-19 tests at supermarkets, pharmacies, and other easy-to-access locations.

Two of the approved tests provide results from oral fluid, requiring a user to spit into a tube to learn their COVID-19 status. The other provides results using a nasal swab.

The tests state they are accurate 97% to 98% of the time.

Can you invest in AM Diagnostics on the ASX?

Understandably, many ASX investors are currently wondering how to get a piece of AM Diagnostics into their portfolio.

Unfortunately, there's no good news for those looking to invest in the manufacture and distributor of medical and diagnostic equipment through AM Diagnostics.  

AM Diagnostics is registered as a private company with the Australian Government. Thus, investors can't buy shares in AM Diagnostics on the ASX.

However, there are several companies that might peak the interest of would-be-AM Diagnostics investors.

Atomo Diagnostics Ltd (ASX: AT1), for instance, is the developer of the CareStart EZ COVID-19 rapid antibody test.

The company's at-home test has been authorised by the US Food and Drug Administration for emergency use.

Another ASX-listed share involved in the COVID-19 home testing market is AnteoTech Ltd (ASX: ADO).

AnteoTech has partnered with unlisted Brisbane-based company, Ellume, to provide its AnteoBind technology for Ellume's at-home COVID-19 tests.

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

CSL share price leaping higher amid $1.9 billion funding news

ASX 200 investors are bidding up the CSL share price on Wednesday.

Read more »

Two happy scientists analysing test results.
Healthcare Shares

Mesoblast share price rockets 36% on breaking FDA news

ASX investors are sending the Mesoblast share price soaring following promising FDA news.

Read more »

a doctor in white coat and stethoscope stands in front of a building holding an electronic device in his hands.
Healthcare Shares

Guess which ASX 200 healthcare share is jumping 7% on a guidance update

This healthcare share is performing better than expected in FY 2024.

Read more »

a biomedical researcher sits at his desk with his hand on his chin, thinking and giving a small smile with a microscope next to him and an array of test tubes and beackers behind him on shelves in a well-lit bright office.
Earnings Results

Chemist Warehouse merger target Sigma reports 149% FY24 profit jump

This could be the last set of results from Sigma as we know it if its merger is approved.

Read more »

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

1 ASX healthcare stock that looks severely undervalued

I think this stock looks too cheap to miss.

Read more »

Stethoscope with a piggy bank and hundred dollar notes.
Healthcare Shares

Own Medibank shares? Here's why it's a rewarding day for you

Shareholders are getting a healthy boost today.

Read more »

Health professional looking at a laptop.
Healthcare Shares

Are CSL shares a must-buy in March?

Let's see what analysts are saying about this high-quality company.

Read more »

A woman jumps for joy with a rocket drawn on the wall behind her.
Healthcare Shares

This ASX healthcare stock is up 72% on FDA news and 'historic moment'

Huge gains are been recorded by this stock on Tuesday. But why?

Read more »